GEN Exclusives

More »

GEN News Highlights

More »
Oct 21, 2009

Exact Sciences Fortifies Position in Stool-Based DNA Detection Through Deal with Hologic

  • Exact Sciences obtained a worldwide license for Hologic’s Invader, Invader plus, and real-time Invader detection chemistries for use in colorectal cancer screening. The Invader chemistry is an accurate, easy-to-use, and rapid molecular detection platform that can be combined with PCR, according to Hologic. Exact anticipates coupling the digital PCR technology it has exclusively licensed from Johns Hopkins University with the quantitative detection capabilities of the Invader chemistry.

    Exact states that this deal reinforces its stronghold in the stool-based DNA, or sDNA, screening market. The company’s IP portfolio now includes exclusive licenses to key detection technologies, sDNA testing methods, and important biomarkers, it adds.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Tackling Climate Change

Do you think most companies will respond positively to the People’s Climate March?